Nipro (NPRRF) Total Liabilities : $5,773 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Nipro Total Liabilities?

Nipro's Total Liabilities for the quarter that ended in Dec. 2023 was $5,773 Mil.

Nipro's quarterly Total Liabilities declined from Jun. 2023 ($5,599.13 Mil) to Sep. 2023 ($5,558.25 Mil) but then increased from Sep. 2023 ($5,558.25 Mil) to Dec. 2023 ($5,773.47 Mil).

Nipro's annual Total Liabilities declined from Mar. 2022 ($6,160.15 Mil) to Mar. 2023 ($5,874.61 Mil) and declined from Mar. 2023 ($5,874.61 Mil) to Mar. 2024 ($5,607.01 Mil).

Nipro Total Liabilities Historical Data

The historical data trend for Nipro's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Total Liabilities Chart

Nipro Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

6,228.73

6,258.98

6,160.15

5,874.61

5,607.01

Nipro Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															5,874.61	5,599.13	5,558.25	5,773.47	5,607.01

Nipro Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nipro's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2446.125	+	(2938.761	+	180.457
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	41.664)
	=	5,607

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	7407.765	-	1800.758
	=	5,607

Nipro's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2489.632	+	(3045.454	+	193.185
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	45.2)
	=	5,773

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	7722.513	-	1949.042
	=	5,773

Nipro Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nipro's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nipro (NPRRF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

8086:Japan

Address

3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510

Website

http://www.nipro.co.jp

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines